15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $28M | -$1M | 41.4% | 6.0% | $1M | $9M | $4M |
| 2024 | $26M | -$2M | 30.0% | -6.2% | -$107822 | $11M | $4M |
| 2023 | $17M | -$6M | 22.1% | -32.9% | -$7M | — | $978741 |
| 2022 | $19M | -$2M | 41.2% | -12.4% | -$6M | $19M | $6M |
| 2021 | $19M | -$78292 | 45.0% | 1.3% | -$2M | $812207 | $10M |
| 2020 | $15M | -$1M | 44.7% | -9.0% | -$3M | $9M | $7M |
| 2019 | — | -$1M | — | — | -$1M | $8M | $6M |
| 2018 | — | -$2M | — | — | -$2M | $9M | $3M |
| 2017 | — | -$168147 | — | — | -$17M | $9M | $4M |
| 2016 | — | $508448 | — | — | -$4M | — | $5M |
| 2015 | — | $1M | — | — | $181047 | — | $2M |
| 2014 | — | -$167159 | — | — | -$1M | — | $850028 |
| 2013 | — | $117395 | — | — | $500963 | $929226 | $2M |
| 2012 | — | $89512 | — | — | $68995 | $1M | $3M |
| 2011 | — | -$409510 | — | — | -$281050 | $1M | $781516 |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $10M | $2M | 45.0% | 19.0% | $3M | $9M | $7M |
| Dec '25 | $8M | -$3M | 38.2% | -0.8% | $310235 | $9M | $4M |
| Sep '25 | $6M | -$139748 | 42.9% | 0.4% | -$2M | $9M | $4M |
| Jun '25 | — | $501880 | — | — | $1M | $10M | — |
| Mar '25 | $8M | $1M | 41.6% | 13.9% | $1M | $10M | — |
| Dec '24 | $8M | $514555 | 36.5% | 8.0% | -$199267 | $11M | $4M |
| Sep '24 | $6M | -$701690 | 26.3% | -9.6% | -$727743 | — | — |
| Jun '24 | — | -$2M | — | — | $471039 | — | $1M |
| Mar '24 | — | -$437868 | — | — | $348149 | — | $960347 |
| Dec '23 | $5M | -$1M | 24.7% | -19.7% | -$804415 | — | $978741 |
| Sep '23 | $5M | -$940000 | 23.5% | -21.9% | -$928269 | $12M | $2M |
| Jun '23 | — | -$1M | — | — | -$1M | $10M | — |
| Mar '23 | — | -$2M | — | — | -$3M | $10M | $3M |
| Dec '22 | $4M | -$2M | 25.4% | -41.8% | -$3M | $19M | $6M |
| Sep '22 | $5M | -$655078 | 38.5% | -12.9% | -$2M | $10M | $9M |
| Jun '22 | — | -$684148 | — | — | -$569832 | $11M | $11M |
| Mar '22 | — | $513287 | — | — | -$168961 | $697793 | $12M |
| Dec '21 | $5M | $74134 | 47.0% | 2.7% | -$116701 | $812207 | $10M |
| Sep '21 | $5M | $147764 | 47.0% | 5.3% | -$416409 | $192928 | $10M |
| Jun '21 | — | $141113 | — | — | -$148507 | $383310 | $11M |
How the market has priced ICCC against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, IMMUCELL CORP /DE/'s revenue has grown 12.5% per year. These are computed facts, not advice.
As of FY2025, IMMUCELL CORP /DE/ reported $9M of total debt against $4M of cash; operating income covered interest expense 3.3×.
In FY2025, gross margin was 41.4%, operating margin 6.0%, and net margin -3.8%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.